Abattis confirms breakthrough CBD oil extraction technology. Expects it to revolutionize the industry.

Abattis Bioceuticals (CSE:ATT) (OTC:ATTBF) announced the completion of experiments confirming the feasibility of column chromatography extraction technology for extracting CBD, THC, and THCA from industrial hemp and cannabis.

According to Abattis’ CEO, Rob Abenante, “The extraction method… is capable of extraction on an industrial scale, which delivers significant cost advantages.”

The technology is also able to recover 99% of all cannabinoids from the biomass. Conventional methods only yield up to 80%.

“The technology has the potential to revolutionize the extraction process for most cannabis derivatives for the entire sector,” stated Mr. Abenante. Using this technology, Abattis intends to offer its extraction services to the largest producers in North America, giving them competitive cost advantages over producers using other techniques.

The stock closed today at $0.39. It has doubled since the announcement. The company has a market cap of $74 million and a 52-week trading range of $0.05 to $0.58.

Dr. Frank Zhu, the key developer and owner of the technology, installed the demonstration apparatus at Abattis’ faculties to confirm the technology. The experiments extracted up to 75 kilograms of biomass per day. According to Zhu, the technology is already being used elsewhere for up to 50,000 kilograms of biomass per day.

“I am very pleased to finally demonstrate the capabilities of the column chromatography technology when applied to cannabinoid extraction,” stated Frank Zhu.

Other test findings:

The technology removes all traces of pesticides and impurities from the cultivation and transportation process.
A factory running at a 500 kg-per-day processing rate could process CBD at less than $0.20/gram.
The cost of capital equipment and operations is less than half of conventional CO2 processes.

Abattis is a life sciences and biotechnology company which invests in cannabis technologies in Canada. The company has developed natural health products, medicines, extractions, and ingredients.

Source Abattis press release

Abattis confirms breakthrough CBD oil extraction technology. Expects it to revolutionize the industry.

About Cannin.com: Your Marijuana Stocks Resource

Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.

Use Cannin as your resource for:

Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.

Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?

Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
108% Backtested since 2012

We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Hemp Stocks to Buy

Abattis confirms breakthrough CBD oil extraction technology. Expects it to revolutionize the industry.